Viglya was launched in early 2012 to serve the bio- and pharmaceutical industries in key aspects of drug development and product life cycle management.  We are dedicated to becoming a key strategic partner in the area of life science and by working closely with our clients we offer our extensive expertise and profound knowledge of the international regulatory landscape as an extension of our client’s internal teams.  Viglya is passionate about its projects and takes pride in helping customers grow.